bpc 157 pharmaceutical grade Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- to the 503A Bulks List for use in compounding for BPC-157 (Body Protection Compound) |

Lipo C injections are similarly unlicensed, and neither treatment is recommended or funded by NICE or the NHS

FDA Approval Update | #FDA Advisory Committee Recommends Changing Restrictions on Several Research #Peptides An FDA advisory committee has voted to recommend allowing several peptides, including BPC-157, TB-500, KPV, and MOTS-c to be compounded by licensed pharmacies

BPC-157 is not FDA-approved for any medical use and is classified as a research peptide

[#2] catecholamines Direct-acting titratable adrenergic agonists are safe to give, with cautious titration to effect (e.g., epinephrine, norepinephrine, phenylephrine, isoproterenol, dobutamine)